Metacrine, Inc. Quarterly Operating Income (Loss) in USD from Q3 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Metacrine, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2022.
  • Metacrine, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$5.16M, a 71.4% increase year-over-year.
  • Metacrine, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$36.5M, a 37.7% increase year-over-year.
  • Metacrine, Inc. annual Operating Income (Loss) for 2021 was -$61.1M, a 66.5% decline from 2020.
  • Metacrine, Inc. annual Operating Income (Loss) for 2020 was -$36.7M, a 22.3% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$36.5M -$5.16M +$12.9M +71.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$49.4M -$5.77M +$9.6M +62.5% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$59M -$12.5M +$2.04M +14% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$61.1M -$13.1M -$2.46M -23.1% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-30
Q3 2021 -$58.6M -$18.1M -$9.17M -103% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$49.5M -$15.4M -$6.17M -67.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$43.3M -$14.6M -$6.59M -82.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$36.7M -$10.6M -$3.18M -42.7% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-18
Q3 2020 -$33.5M -$8.91M -$194K -2.23% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$33.3M -$9.19M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$7.96M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$7.45M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$8.72M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.